Of the six patients included, four had anti-NMDAR encephalitis (one post-HSV), and two met the Graus et al. 2016 criteria for possible seronegative AE. Longitudinal comparisons were available for one anti-NMDAR encephalitis case and one seronegative case. Five had pre-existing neurodevelopmental conditions, and three received special education services. Among the three non-post-HSV anti-NMDAR encephalitis cases (ages 5-17; n=3), functional outcomes were generally favorable, but impairments existed in attention, visuospatial, fine motor, and executive functions. The two possible seronegative cases demonstrated favorable functional outcomes with milder cognitive impacts, although one patient exhibited fluctuating performance with disease flare. Available longitudinal data showed partial recovery with domain-level performance reflecting evolving strengths and weaknesses over time. The post-HSV anti-NMDAR encephalitis case with onset at 13 months of resulted in severe, persistent neurodevelopmental impairment and limited functional recovery.